Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone

Am J Hematol. 2006 Jun;81(6):471-3. doi: 10.1002/ajh.20599.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced*
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, T-Cell / complications
  • Lymphoma, T-Cell / drug therapy*
  • Male
  • Mitoxantrone / administration & dosage
  • Mitoxantrone / adverse effects
  • Myelodysplastic Syndromes / chemically induced*
  • Neoplasms, Second Primary / chemically induced*
  • Vidarabine / administration & dosage
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives

Substances

  • Antineoplastic Agents
  • Dexamethasone
  • Mitoxantrone
  • Vidarabine
  • fludarabine